Literature DB >> 176959

Benign liver cell adenoma associated with use of oral contraceptive agents.

S Baek, C E Sloane, S C Futterman.   

Abstract

A benign hepatic adenoma in a young woman taking oral contraceptives for 7 years is reported. The diagnosis must be suspected in any young woman taking oral contraceptive agents who develop signs and symptoms of acute cholecystitis with hepatomegaly or mass, or when signs and symptoms of non-traumatic intraabdominal hemorrhage are present. Rupture of the tumor is a life-threatening complication. Treatment should be either hepatic lobectomy or wide local resection.

Entities:  

Keywords:  Biology; Case Studies; Contraception; Contraceptive Agents, Estrogen--side effects; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--side effects; Contraceptive Methods--side effects; Family Planning; Hepatic Effects; Mestranol--side effects; Norethindrone--side effects; Oral Contraceptives, Combined; Oral Contraceptives--side effects; Physiology; Research Methodology; Studies

Mesh:

Substances:

Year:  1976        PMID: 176959      PMCID: PMC1344229          DOI: 10.1097/00000658-197603000-00003

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  12 in total

1.  Hemoperitoneum from liver cell adenoma in a patient on oral contraceptives.

Authors:  K Antoniades; C E Brooks
Journal:  Surgery       Date:  1975-01       Impact factor: 3.982

2.  Letter: Hepatomas and oral contraceptives.

Authors:  W A Knapp; B H Ruebner
Journal:  Lancet       Date:  1974-02-16       Impact factor: 79.321

3.  Letter: Liver tumours and steroid hormones.

Authors:  D Cattan; P Vesin; J Wautier; R Kalifat; S Meignan
Journal:  Lancet       Date:  1974-05-04       Impact factor: 79.321

4.  Letter: Benign hepatoma in a young woman on contraceptive steroids.

Authors:  E Horvath; K Kovacs; R C Ross
Journal:  Lancet       Date:  1974-03-02       Impact factor: 79.321

5.  Androgenic-anabolic steroid therapy and hepatocellular carcinoma.

Authors:  J T Henderson; J Richmond; M D Sumerling
Journal:  Lancet       Date:  1973-04-28       Impact factor: 79.321

6.  Letter: Benign hepatomas and oral contraceptives.

Authors:  D L Contostavlos
Journal:  Lancet       Date:  1973-11-24       Impact factor: 79.321

7.  Letter: Liver-cell neoplasms and oral contraceptives.

Authors:  C H Lingeman
Journal:  Lancet       Date:  1974-01-12       Impact factor: 79.321

8.  Possible association between benign hepatomas and oral contraceptives.

Authors:  J K Baum; J J Bookstein; F Holtz; E W Klein
Journal:  Lancet       Date:  1973-10-27       Impact factor: 79.321

9.  Androgens and hepatocellular carcinoma.

Authors:  J Ziegenfuss; R Carabasi
Journal:  Lancet       Date:  1973-02-03       Impact factor: 79.321

10.  Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma.

Authors:  F L Johnson; K G Lerner; M Siegel; J R Feagler; P W Majerus; J R Hartmann; E D Thomas
Journal:  Lancet       Date:  1972-12-16       Impact factor: 79.321

View more
  7 in total

1.  Benign hepatic lesions in women taking oral contraceptives.

Authors:  T J Davis; R N Berk
Journal:  Gastrointest Radiol       Date:  1977-12-20

Review 2.  Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases.

Authors:  Jan H M B Stoot; Robert J S Coelen; Mechteld C De Jong; Cornelis H C Dejong
Journal:  HPB (Oxford)       Date:  2010-10       Impact factor: 3.647

3.  Focal nodular hyperplasia of the liver imaging by differing modalities.

Authors:  V J D'Souza; T E Sumner; N E Watson; A G Formanek
Journal:  Pediatr Radiol       Date:  1983

4.  Pregnancy and liver adenoma management: PALM-study.

Authors:  Susanna M van Aalten; Mirelle E E Bröker; J J V Busschbach; Harry J de Koning; Robert A de Man; Eric A P Steegers; Ewout W Steyerberg; Turkan Terkivatan; Jan N M Ijzermans
Journal:  BMC Gastroenterol       Date:  2012-06-29       Impact factor: 3.067

5.  Management and outcome of hepatocellular adenoma with massive bleeding at presentation.

Authors:  Anne J Klompenhouwer; Robert A de Man; Maarten Gj Thomeer; Jan Nm Ijzermans
Journal:  World J Gastroenterol       Date:  2017-07-07       Impact factor: 5.742

6.  The management of pregnancy in women with hepatocellular adenoma: a plea for an individualized approach.

Authors:  Mirelle E E Bröker; Jan N M Ijzermans; Susanna M van Aalten; Robert A de Man; Türkan Terkivatan
Journal:  Int J Hepatol       Date:  2012-12-24

Review 7.  New insights in the management of Hepatocellular Adenoma.

Authors:  Anne J Klompenhouwer; Robert A de Man; Marco Dioguardi Burgio; Valerie Vilgrain; Jessica Zucman-Rossi; Jan N M Ijzermans
Journal:  Liver Int       Date:  2020-06-11       Impact factor: 5.828

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.